780405008: Product containing only ruxolitinib in oral dose form (medicinal product form)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Ruxolitinib\Product containing only ruxolitinib in oral dose form (medicinal product form)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing Janus kinase inhibitor\Product containing ruxolitinib\Ruxolitinib\Product containing only ruxolitinib in oral dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing Janus kinase inhibitor\Product containing ruxolitinib\Product containing ruxolitinib in oral dose form (medicinal product form)\Product containing only ruxolitinib in oral dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing ruxolitinib\Ruxolitinib\Product containing only ruxolitinib in oral dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing ruxolitinib\Product containing ruxolitinib in oral dose form (medicinal product form)\Product containing only ruxolitinib in oral dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing ruxolitinib\Ruxolitinib\Product containing only ruxolitinib in oral dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing ruxolitinib\Product containing ruxolitinib in oral dose form (medicinal product form)\Product containing only ruxolitinib in oral dose form (medicinal product form)
\Medicinal product\Product manufactured as oral dose form\Product containing ruxolitinib in oral dose form (medicinal product form)\Product containing only ruxolitinib in oral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3742585010 Ruxolitinib only product in oral dose form en Synonym Active Entire term case insensitive SNOMED CT core module

3742586011 Product containing only ruxolitinib in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing only ruxolitinib in oral dose form (medicinal product form)	Is a	Ruxolitinib	true	Inferred relationship	Existential restriction modifier
Product containing only ruxolitinib in oral dose form (medicinal product form)	Has active ingredient	Ruxolitinib	true	Inferred relationship	Existential restriction modifier	1
Product containing only ruxolitinib in oral dose form (medicinal product form)	Has manufactured dose form	Oral dose form	true	Inferred relationship	Existential restriction modifier
Product containing only ruxolitinib in oral dose form (medicinal product form)	Count of base of active ingredient	1	false	Inferred relationship	Existential restriction modifier
Product containing only ruxolitinib in oral dose form (medicinal product form)	Is a	Product containing ruxolitinib in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing only ruxolitinib in oral dose form (medicinal product form)	Plays role	Antineoplastic therapeutic role	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely ruxolitinib 5 milligram/1 each conventional release oral tablet	Is a	False	Product containing only ruxolitinib in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely ruxolitinib 10 milligram/1 each conventional release oral tablet	Is a	False	Product containing only ruxolitinib in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely ruxolitinib 20 milligram/1 each conventional release oral tablet	Is a	False	Product containing only ruxolitinib in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely ruxolitinib 25 milligram/1 each conventional release oral tablet	Is a	False	Product containing only ruxolitinib in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely ruxolitinib 15 milligram/1 each conventional release oral tablet	Is a	False	Product containing only ruxolitinib in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Is a	True	Product containing only ruxolitinib in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Is a	True	Product containing only ruxolitinib in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 20 milligram/1 each conventional release oral tablet (clinical drug)	Is a	True	Product containing only ruxolitinib in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 15 milligram/1 each conventional release oral tablet (clinical drug)	Is a	True	Product containing only ruxolitinib in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug)	Is a	True	Product containing only ruxolitinib in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3742585010	Ruxolitinib only product in oral dose form	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3742586011	Product containing only ruxolitinib in oral dose form (medicinal product form)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module